PERINDOPRIL TERT-BUTYLAMINE/INDAPAMIDE CRISTERS 8 mg/2.5 mg, tablet 90 tablets
Active ingredients: Indapamide, Perindopril, Perindopril erbumine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet90 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PERINDOPRIL TERT-BUTYLAMINE/INDAPAMIDE CRISTERS 8 mg/2,5 mg, comprimé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium PVC de 90 comprimé(s)
- Marketing authorisation holder
- CRISTERS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Jul 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67670538CIP73029817CIP133400930298176Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INDAPAMIDEcomprimé | 2,500 mg · un comprimé | SA |
| PÉRINDOPRIL TERT-BUTYLAMINEcomprimé | 8,000 mg · un comprimé | SA |
| PÉRINDOPRILcomprimé | 6,676 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.